# Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

> **NCT01191684** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Recurrent Colon Cancer
- Recurrent Gastric Cancer
- Recurrent Pancreatic Cancer
- Recurrent Rectal Cancer
- Stage III Colon Cancer
- Stage III Gastric Cancer
- Stage III Pancreatic Cancer
- Stage III Rectal Cancer
- Stage IV Colon Cancer
- Stage IV Gastric Cancer
- Stage IV Pancreatic Cancer
- Stage IV Rectal Cancer

## Interventions

- **OTHER:** laboratory biomarker analysis
- **OTHER:** enzyme-linked immunosorbent assay
- **OTHER:** flow cytometry
- **OTHER:** immunoenzyme technique
- **BIOLOGICAL:** modified vaccinia virus ankara vaccine expressing p53

## Key facts

- **NCT ID:** NCT01191684
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01191684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01191684, "Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01191684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*